We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 101-120 of 6,951 results
  1. The identification of effective tumor-suppressing neoantigens using a tumor-reactive TIL TCR-pMHC ternary complex

    Neoantigens are ideal targets for cancer immunotherapy because they are expressed de novo in tumor tissue but not in healthy tissue and are therefore...

    Sang Hoon Kim, Bo Ryeong Lee, ... Woong-Yang Park in Experimental & Molecular Medicine
    Article Open access 12 June 2024
  2. AMD1 promotes breast cancer aggressiveness via a spermidine-eIF5A hypusination-TCF4 axis

    Background

    Basal-like breast cancer (BLBC) is the most aggressive subtype of breast cancer due to its aggressive characteristics and lack of effective...

    Ruocen Liao, **ngyu Chen, ... Chenfang Dong in Breast Cancer Research
    Article Open access 23 April 2024
  3. Non-canonical role for the ataxia-telangiectasia-Rad3 pathway in STAT3 activation in human multiple myeloma cells

    Purpose

    The goal of this study was to characterize the relationship between ATR and STAT3 interactions in human multiple myeloma (MM) cells.

    ...
    Lin Li, **aoyan Hu, ... Steven Grant in Cellular Oncology
    Article Open access 01 May 2023
  4. Intrabodies targeting human papillomavirus 16 E6 and E7 oncoproteins for therapy of established HPV-associated tumors

    Background

    The oncogenic activity of the high risk human papillomavirus type 16 (HPV16) is fully dependent on the E6 and E7 viral oncoproteins...

    Francesca Paolini, Carla Amici, ... Luisa Accardi in Journal of Experimental & Clinical Cancer Research
    Article Open access 23 January 2021
  5. Targeted demethylation of the SLC5A7 promotor inhibits colorectal cancer progression

    Background

    SLC5A7 (solute carrier family 5 member 7), also known as choline transporter 1 (CHT1), is downregulated in colorectal cancer (CRC) and...

    Yang Li, Baike Liu, ... Yuan Yin in Clinical Epigenetics
    Article Open access 20 July 2022
  6. Discovery of a small molecule ligand of FRS2 that inhibits invasion and tumor growth

    Purpose

    Aberrant activation of the fibroblast growth factor receptor (FGFR) family of receptor tyrosine kinases drives oncogenic signaling through its...

    Karthiga Santhana Kumar, Cyrill Brunner, ... Martin Baumgartner in Cellular Oncology
    Article Open access 10 December 2022
  7. Optimization of the proliferation and persistency of CAR T cells derived from human induced pluripotent stem cells

    The effectiveness of chimaeric antigen receptor (CAR) T-cell immunotherapies against solid tumours relies on the accumulation, proliferation and...

    Tatsuki Ueda, Sara Shiina, ... Shin Kaneko in Nature Biomedical Engineering
    Article Open access 12 December 2022
  8. Triggering pyroptosis enhances the antitumor efficacy of PARP inhibitors in prostate cancer

    Purpose

    PARP inhibitors have revolutionized the treatment landscape for advanced prostate cancer (PCa) patients who harboring mutations in homologous...

    Ao Tian, Tingyu Wu, ... Weiliang **a in Cellular Oncology
    Article 23 August 2023
  9. Comparative genomics of the T cell receptor μ locus in marsupials and monotremes

    T cells are a primary component of the vertebrate adaptive immune system. There are three mammalian T cell lineages based on their T cell receptors...

    K. A. Morrissey, M. R. Stammnitz, ... R. D. Miller in Immunogenetics
    Article 25 September 2023
  10. Primer Design for the Analysis of Closely Related Species: Application of Noncoding mtDNA and cpDNA Sequences

    Noncoding regions of the chloroplast (cpDNA) and mitochondrial (mtDNA) genomes are commonly used in plant phylogenetic and population studies....
    Lidia Skuza in PCR Primer Design
    Protocol 2022
  11. A 192 bp ERV fragment insertion in the first intron of porcine TLR6 may act as an enhancer associated with the increased expressions of TLR6 and TLR1

    Background

    Toll-like receptors (TLRs) play important roles in building innate immune and inducing adaptive immune responses. Associations of the TLR ...

    **aoYan Wang, Zixuan Chen, ... Chengyi Song in Mobile DNA
    Article Open access 18 August 2021
  12. Transcriptome Profiling Analysis Identifies LCP1 as a Contributor for Chidamide Resistance in Gastric Cancer

    Background

    Gastric cancer (GC) remains a significant health problem and carries with it substantial morbidity and mortality. Chidamide is a novel and...

    Wenfang Bao, Zhe Zhu, ... **gde Chen in Pharmaceutical Research
    Article 16 May 2022
  13. A novel SLC5A2 heterozygous variant in a family with familial renal glucosuria

    Familial renal glucosuria (FRG) is characterized by persistent glucosuria despite normal blood glucose levels in the absence of overt tubular...

    Maho Hatano, Tomohiro Udagawa, ... Masato Nishioka in Human Genome Variation
    Article Open access 01 December 2022
  14. KRASG12C inhibition using MRTX1257: a novel radio-sensitizing partner

    Background

    KRAS activating mutations are considered the most frequent oncogenic drivers and are correlated with radio-resistance in multiple cancers...

    Pierre-Antoine Laurent, Marina Milic, ... Eric Deutsch in Journal of Translational Medicine
    Article Open access 31 October 2023
  15. METTL3 suppresses pancreatic ductal adenocarcinoma progression through activating endogenous dsRNA-induced anti-tumor immunity

    Purpose

    Although immunotherapy improves clinical outcomes in several types of malignancies, as an immunologically ‘cold’ tumor, pancreatic ductal...

    Lili Zhu, Botai Li, ... Xueli Zhang in Cellular Oncology
    Article 13 May 2023
  16. Suspected olfactory meningioma and synchronous pituitary microadenoma in a canine patient treated with radiation therapy

    The authors report on the rare occurrence of dual synchronous primary brain tumors in a canine patient, successful treatment with radiation therapy,...

    Isabelle F. Vanhaezebrouck, Carlos R. Mendez Valenzuela, ... Kari Ekenstedt in Veterinary Oncology
    Article Open access 16 July 2024
  17. A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive cancers with a very low survival rate at 5 years. The use of...

    Davide Busato, Sara Capolla, ... Giuseppe Toffoli in Journal of Translational Medicine
    Article Open access 28 November 2023
  18. circ-TFRC downregulation suppresses ovarian cancer progression via miR-615-3p/IGF2 axis regulation

    Background

    Ovarian cancer (OC) is a malignancy among female globally. Circular RNAs (circRNAs) are a family of circular endogenous RNAs generated from...

    Zhongxin Yan, Changling Duan, ... Yi Miao in Cancer Cell International
    Article Open access 27 April 2024
  19. APC/PIK3CA mutations and β-catenin status predict tankyrase inhibitor sensitivity of patient-derived colorectal cancer cells

    Background

    Aberrant WNT/β-catenin signaling drives carcinogenesis. Tankyrases poly(ADP-ribosyl)ate and destabilize AXINs, β-catenin repressors....

    Mingjue Chen, Tetsuo Mashima, ... Hiroyuki Seimiya in British Journal of Cancer
    Article 15 November 2023
  20. Survival time prediction in patients with high-grade serous ovarian cancer based on 18F-FDG PET/CT- derived inter-tumor heterogeneity metrics

    Background

    The presence of heterogeneity is a significant attribute within the context of ovarian cancer. This study aimed to assess the predictive...

    Dianning He, **n Zhang, ... Beibei Li in BMC Cancer
    Article Open access 12 March 2024
Did you find what you were looking for? Share feedback.